glp-1 lizard saliva How a Canadian scientist and a venomous helped pave the way for Ozempic The discovery of a digestion-slowing

Regular monitoring allows for timely dose adjustments and ensures both diabetes or weight management goals and thyroid function optimization are achieved safely

Personalizing busulfan-based conditioning: considerations from the American society for blood and marrow transplantation practice guidelines committee

The findings of a large US real-world cohort (n= 18,000) study, published in 2024, show that patients on tirzepatide were significantly more likely to achieve 5 %, 10 % and 15 % weight loss compared with semaglutide (HR 1.76, 2.54, 3.24, respectively), with a 12-month mean weight difference of -6.9% 8

More specifically, it is intended for individuals with a body mass index (BMI) above 30 kg/m2 (obese) or those with a BMI of 27 kg/m2 or greater (overweight) who have at least one weight-related comorbidity such as hypertension, type 2 diabetes mellitus, or dyslipidemia

Knerr et al., 2022)